Crizotinib-d9

CAT: 0804-HY-50878S2Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-50878S2Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Crizotinib-d9 (PF-02341066-d9) is deuterium labeled Crizotinib. Crizotinib (PF-02341066) is an orally bioavailable, ATP-competitive ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC50s of 24 and 11 nM in cell-based assays, respectively. Crizotinib is also a ROS1 inhibitor. Crizotinib has effective tumor growth inhibition[1][2][3].
CAS Number
[1523580-59-7]
Product Name Alternative
PF-02341066-d9
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
C[C@H](C1=C(C(F)=CC=C1Cl)Cl)OC2=CC(C3=CN(C4([2H])C([2H])([2H])C([2H])([2H])NC([2H])([2H])C4([2H])[2H])N=C3)=CN=C2N
Molecular Formula
C21H13D9Cl2FN5O
Molecular Weight
459.39
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-50878-01Crizotinib
HY-149696IR-Crizotinib
HY-50878S1Crizotinib-d8
HY-100549-01(S) -Crizotinib
HY-50878A-01Crizotinib (hydrochloride)
HY-50878R-01Crizotinib (Standard)
HY-50878BCrizotinib (acetate)
HY-50878SCrizotinib-d5
HY-75468-01Crizotinib impurity 1
HY-100549R(S) -Crizotinib (Standard)

Alternative Products

CatalogName
T1661-01Crizotinib
RM-C182606-01(S) -Crizotinib
T8399-01Crizotinib hydrochloride
MBS578906(S)-crizotinib
A3020-100(R)-Crizotinib
007107Crizotinib discontinued
T82049-01IR-Crizotinib
T1661L-01Crizotinib acetate

Popular Products